TrialJAMA ophthalmology2013

Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial.

Francisco Amparo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.